RECURSION PHARMACEUTICALS, INC. (RXRX)

SEC filing

RECURSION PHARMACEUTICALS, INC.

RXRX · CIK 1601830

4 · Nov 19, 2025 · Gibson Christopher sold 40K shares at $4.16/share ($166.4K); converted 40K shares; reported 40.39K shares

Gibson Christopher sold 40K shares at $4.16/share ($166.4K); converted 40K shares; reported 40.39K shares

FORM 4

xslF345X05/wk-form4_1763599043.xmlSEC.gov

Graphics and non-inline formats (not embedded below).